文献速递乳腺技术与安全CT

亚洲可手术乳腺癌患者中连续CT测量的骨骼肌减少与内脏肥胖对预后的影响

Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients.
PubMed 文献 · Korean J Radiol · 2022-01-06

该回顾性研究纳入627例亚洲女性乳腺癌(I-III期)术后患者,利用基线与随访腹部CT半自动测量骨骼肌指数(SMI)和内脏脂肪面积(VAT),分析其与无病生存的关系。中位随访40.5个月,56例(9.2%)复发;多变量Cox回归显示基线及早期变化的SMI和VAT均非无病生存的独立预后因素。

要点

  • 基线SMI与VAT均与无病生存无显著关联(调整HR 0.983和1.001)。
  • SMI与VAT的早期变化亦与无病生存无显著关联(调整HR 0.894和1.001)。
  • 在亚洲可手术乳腺癌患者中,CT体成分参数未显示独立预后价值。

核心结论

  • 基线及早期时间变化的SMI和VAT在接受手术的亚洲乳腺癌患者中并非无病生存的独立预后因素。

研究设计与样本

  • 回顾性研究纳入627例亚洲女性(平均年龄53.6±8.3岁),于2011年1月至2012年9月期间接受I-III期乳腺癌手术;在基线诊断时和随访监测CT上半自动计算SMI和VAT,计算差值,采用多变量Cox回归分析。

诊断标准与关键数值

  • 基线SMI均值±SD为43.7±5.8 cm²/m²,基线VAT均值±SD为72.0±46.0 cm²。
  • delta SMI均值为-0.9 cm²/m²,delta VAT均值为0.5 cm²。
  • 基线SMI与无病生存无关:调整HR 0.983(95%CI 0.937-1.031;p=0.475)。
  • 基线VAT与无病生存无关:调整HR 1.001(95%CI 0.995-1.006;p=0.751)。
  • delta SMI与无病生存无关:调整HR 0.894(95%CI 0.766-1.043;p=0.155);delta VAT与无病生存无关:调整HR 1.001(95%CI 0.989-1.014;p=0.848)。

临床应用与阅片要点

  • 本研究未发现基线和早期SMI、VAT变化与无病生存独立相关,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to investigate the impact of baseline values and temporal changes in body composition parameters, including skeletal muscle index (SMI) and visceral adipose tissue area (VAT), measured using serial computed tomography (CT) imaging on the prognosis of operable breast cancers in Asian patients.

MATERIALS AND METHODS: This study retrospectively included 627 Asian female (mean age ± standard deviation [SD], 53.6 ± 8.3 years) who underwent surgery for stage I-III breast cancer between January 2011 and September 2012. Body composition parameters, including SMI and VAT, were semi-automatically calculated on baseline abdominal CT at the time of diagnosis and follow-up CT for post-treatment surveillance. Serial changes in SMI and VAT were calculated as the delta values. Multivariable Cox regression analysis was used to evaluate the association of baseline and delta SMI and VAT values with disease-free survival.

RESULTS: Among 627 patients, 56 patients (9.2%) had breast cancer recurrence after a median of 40.5 months. The mean value ± SD of the baseline SMI and baseline VAT were 43.7 ± 5.8 cm²/m² and 72.0 ± 46.0 cm², respectively. The mean value of the delta SMI was -0.9 cm²/m² and the delta VAT was 0.5 cm². The baseline SMI and VAT were not significantly associated with disease-free survival (adjusted hazard ratio [HR], 0.983; 95% confidence interval [CI], 0.937-1.031; p = 0.475 and adjusted HR, 1.001; 95% CI, 0.995-1.006; p = 0.751, respectively). The delta SMI and VAT were also not significantly associated with disease-free survival (adjusted HR, 0.894; 95% CI, 0.766-1.043; p = 0.155 and adjusted HR, 1.001; 95% CI, 0.989-1.014; p = 0.848, respectively).

CONCLUSION: Our study revealed that baseline and early temporal changes in SMI and VAT were not independent prognostic factors regarding disease-free survival in Asian patients undergoing surgery for breast cancer.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kwon, Ko, Park, et al. Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients. Korean J Radiol. 2022. PMID: 35029082. doi:10.3348/kjr.2020.1475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。